Pengfei Wu

ORCID: 0000-0002-1253-3344 · 3 papers in corpus
diagnostic-accuracy 2026
Artificial intelligence-driven integration of multi-biofluid omics and clinical phenotype enables stratification of endometrial cancer
Cell reports. Medicine ·doi:10.1016/j.xcrm.2026.102805

Endometrial cancer (EC) incidence is rising, yet current diagnostics lack precision and scalability. We develop an artificial intelligence (AI)-based platform integrating multi-biofluid omics and clinical data for EC stratification. Using t…

case-report 2025
Case Report: Spontaneous pregnancy after fertility-preserving treatment in a patient with low-grade endometrial stromal sarcoma and literature review
Frontiers in oncology ·doi:10.3389/fonc.2025.1572914

INTRODUCTION: Low-grade endometrial stromal sarcoma (LGESS) is a rare malignant tumor of the uterus, characterized by slow growth. Early-stage LGESS is associated with favorable survival, but it has a high recurrence rate. The primary treat…

rct 2023
Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study
Gynecologic Oncology ·doi:10.1016/j.ygyno.2023.05.001

OBJECTIVE: To compare the effects of levonorgestrel-intrauterine system (LNG-IUS) with or without oral megestrol acetate (MA) versus MA alone on fertility-preserving treatment in patients with atypical endometrial hyperplasia (AEH). METHOD…